BIOMARIN PHARMACEUTICAL (NASDAQ:BMRN) is an undervalued biotech stock with strong profitability, solid financial health, and reasonable growth prospects, making it a candidate for value investors.
ALPHABET INC-CL C (GOOG) shows strong growth fundamentals and a promising technical setup, making it a stock worth watching for investors seeking growth opportunities.
Britain was the first country to clinch an agreement with the U.S., resulting in the removal of the tariffs imposed on steel and auto even as the baseline 10% tariff stayed.
U.S. Health Secretary Robert F. Kennedy Jr. praised the Food and Drug Administration's decision to begin removing fluoride supplements for children from the market, calling the move "long overdue."
U.S. trade tariffs, which would increase manufacturing prices in Southeast Asian nations, on which Under Armour relies, add pressure to the already sluggish business.
